drugset / Trial / NCT01395485

Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma

NCT01395485

Phase 1 Withdrawn Amgen
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics in adolescent and adult subjects with intermittent or mild to moderate persistent asthma.

Timeline

Start
2011-06
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Brodalumab Monoclonal antibody Subcutaneous

Indications